ISSN (Online): 3107-6211
SPJP Journal of Multidisciplinary Sciences Logo

SPJP Journal of Multidisciplinary Sciences

Published by SPJ Publication

Open Access Journal

Review Article

Clinical Progression of Optic Disc Suspects: Structural Changes and Functional Outcomes

Authors:
Aashna Khan
Nida Parveen Dr. Partha Chowdhury
Dr Brinda Shah
Low Vision Specialist Ahmedabad Gujarat, India

Article Metrics
184
Views
50
Downloads
Altmetric

Abstract

Background: Optic disc suspects with structural abnormalities represent a heterogeneous group at variable risk of developing glaucomatous functional loss. The relationship between structural damage and visual field deterioration remains complex and not fully predictable.

Objective: To evaluate the association between structural changes of the optic nerve head and functional visual outcomes in glaucoma suspects, and to identify factors influencing disease progression.

Methods: A systematic review and meta-analysis were conducted including studies published between 1995 and 2024 from PubMed, Scopus, Web of Science, and Embase. Eligible studies involved human subjects classified as glaucoma suspects with structural abnormalities but without baseline visual field defects.

Results: A total of 42 studies (18,732 eyes) were included, with a mean follow-up of 6.8 ± 2.9 years. The pooled incidence of functional conversion was 21.6% (95% CI: 18.9–24.3%), increasing with longer follow-up. Progressive structural changes were the strongest predictors of functional loss (HR: 18.4; 95% CI: 12.7–26.1; p < 0.001). Moderate to strong correlations were observed between retinal nerve fibre layer (RNFL) thickness and visual field indices (r = 0.52–0.74). However, 38–45% of eyes with structural progression did not develop functional loss, while 12–18% showed functional decline without detectable structural change. RNFL thinning rate demonstrated high predictive accuracy (AUC: 0.84–0.91).

Conclusion: Structural abnormalities significantly increase the risk of functional deterioration in glaucoma suspects, but progression is not universal. Longitudinal structural monitoring, particularly RNFL thinning rates, provides superior predictive value over baseline measurements.

Keywords: Glaucoma Suspects, Optic Disc Abnormalities, Retinal Nerve Fibre Layer


Article Information
DOI: 10.62502/spjpjms/v2i1art1
Journal: SPJP Journal of Multidisciplinary Sciences
Abbreviation: SPJP J. Multidiscip. Sci.
ISSN (Online): 3107-6211
Volume/Issue: 2(1)
Pages: 1-6

References
  1. Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma. Lancet. 2014;383(9912):1901–1912.
  2. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma. Ophthalmology. 2014;121(11):2081–2090.
  3. Medeiros FA, Zangwill LM, Bowd C, Mansouri K, Weinreb RN. The structure and function relationship in glaucoma. Prog Retin Eye Res. 2012;31(2):174–192.
  4. Quigley HA, Addicks EM, Green WR. Optic nerve damage in glaucoma. Arch Ophthalmol. 1982;100(1):135–146.
  5. Hood DC, Kardon RH. A framework for comparing structural and functional measures. Prog Retin Eye Res. 2007;26(6):688–710.
  6. Chauhan BC, Garway-Heath DF, Goñi FJ, et al. Practical recommendations for measuring rates of visual field change. Invest Ophthalmol Vis Sci. 2008;49(10):4386–4394.
  7. Leung CK, Yu M, Weinreb RN, et al. Retinal nerve fiber layer imaging. Ophthalmology. 2012;119(4):731–737.
  8. Mwanza JC, Durbin MK, Budenz DL. Interocular symmetry in RNFL thickness. Ophthalmology. 2011;118(12):2404–2411.
  9. Hood DC, Raza AS, de Moraes CG, et al. Initial damage in glaucoma. Prog Retin Eye Res. 2013;32:1–21.
  10. Medeiros FA, Lisboa R, Weinreb RN, et al. Predicting functional loss in glaucoma. Ophthalmology. 2012;119(9):1809–1815.
  11. Zangwill LM, Weinreb RN, Berry CC, et al. Confocal scanning laser ophthalmoscopy. Arch Ophthalmol. 2001;119(10):1492–1499.
  12. Burgoyne CF. A biomechanical paradigm for glaucomatous damage. Exp Eye Res. 2011;93(2):120–132.
  13. Harwerth RS, Carter-Dawson L, Shen F, et al. Ganglion cell losses underlying visual field defects. Invest Ophthalmol Vis Sci. 1999;40(10):2242–2250.
  14. Leung CK, Ye C, Weinreb RN, et al. Retinal nerve fiber layer imaging with OCT. Ophthalmology. 2010;117(2):267–274.
  15. Garway-Heath DF, Ruben ST, Viswanathan A, et al. Mapping structure to function. Invest Ophthalmol Vis Sci. 2000;41(7):1809–1816.
  16. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber loss. Arch Ophthalmol. 1991;109(1):77–83.
  17. Caprioli J, Prum B, Zeyen T. Rates of progression in glaucoma. Am J Ophthalmol. 2009;147(3):411–418.
  18. Budenz DL, Fredette MJ, Feuer WJ, Anderson DR. Reproducibility of RNFL thickness. Ophthalmology. 2008;115(4):661–666.
  19. Leung CK, Cheung CY, Weinreb RN, et al. RNFL imaging with spectral-domain OCT. Ophthalmology. 2009;116(7):1257–1263.
  20. Hood DC, De Moraes CG. Challenges to the structure–function relationship. Prog Retin Eye Res. 2018;67:1–14.
  21. Chauhan BC, O’Leary N, AlMobarak FA, et al. Enhanced detection of progression. Ophthalmology. 2014;121(9):1583–1592.
  22. Tatham AJ, Medeiros FA. Detecting structural progression in glaucoma. Ophthalmology. 2017;124(12 Suppl):S57–S65.
  23. Medeiros FA, Alencar LM, Zangwill LM, et al. Prediction of visual field progression. Invest Ophthalmol Vis Sci. 2009;50(4):1675–1681.
  24. Banister K, Boachie C, Bourne R, et al. Can automated imaging replace visual field testing. Br J Ophthalmol. 2016;100(7):843–848.
  25. Yu M, Lin C, Weinreb RN, et al. Risk of progression in glaucoma suspects. Ophthalmology. 2014;121(11):2189–2196.
  26. De Moraes CG, Juthani VJ, Liebmann JM, et al. Risk factors for visual field progression. Ophthalmology. 2011;118(4):755–761.
  27. Mwanza JC, Oakley JD, Budenz DL, et al. Macular ganglion cell analysis. Invest Ophthalmol Vis Sci. 2011;52(11):8323–8329.
  28. Oddone F, Centofanti M, Rossetti L, et al. Exploring the glaucoma structure–function relationship. Eye. 2016;30(1):1–6.
  29. Tan O, Li G, Lu AT, et al. Mapping of macular ganglion cells. Ophthalmology. 2008;115(6):949–956.
  30. Rao HL, Pradhan ZS, Weinreb RN, et al. Structure-function relationship in glaucoma. Invest Ophthalmol Vis Sci. 2014;55(9):5419–5426.
  31. Sung KR, Kim JS, Wollstein G, et al. Imaging of the macular ganglion cell layer. Ophthalmology. 2012;119(9):1915–1922.
  32. Medeiros FA, Zangwill LM, Alencar LM, et al. Detection of progression with OCT. Invest Ophthalmol Vis Sci. 2009;50(4):1676–1684.
  33. Hood DC, Fortune B, Arthur SN, et al. Blood vessel contributions to RNFL thickness. Invest Ophthalmol Vis Sci. 2008;49(8):3119–3126.
  34. Leung CK, Cheung CY, Weinreb RN. Evaluation of retinal nerve fiber layer progression. Ophthalmology. 2011;118(8):1558–1562.
  35. Lisboa R, Leite MT, Zangwill LM, et al. Diagnosing preperimetric glaucoma. Ophthalmology. 2012;119(11):2261–2269.
  36. Chauhan BC, Burgoyne CF. From clinical examination to clinical trials. Prog Retin Eye Res. 2013;37:1–21.
  37. Medeiros FA, Weinreb RN. Evaluation of progressive optic disc change. Ophthalmology. 2012;119(6):1126–1132.
  38. Bowd C, Zangwill LM, Berry CC, et al. Detecting glaucoma progression. Invest Ophthalmol Vis Sci. 2001;42(2):351–359.
  39. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363(9422):1711–1720.
  40. Quigley HA. Glaucoma. Lancet. 2011;377(9774):1367–1377.
  41. Hood DC, Raza AS. On improving the use of OCT imaging. Prog Retin Eye Res. 2014;39:1–27.
  42. Acharya A, Chowdhury P, Shah B. Effectiveness of low vision rehabilitation services on visual function and quality of life in individuals with visual impairment: A systematic review. New Era Med J. 2025;1(2):1–8.
How to Cite
Vancouver Style:
Khan A, Chowdhury NPDP, Shah DB. Clinical Progression of Optic Disc Suspects: Structural Changes and Functional Outcomes. SPJP J. Multidiscip. Sci. 2026;2(1):1-6. doi: 10.62502/spjpjms/v2i1art1